185 related articles for article (PubMed ID: 37739953)
1. Acetylation discriminates disease-specific tau deposition.
Chakraborty P; Rivière G; Hebestreit A; de Opakua AI; Vorberg IM; Andreas LB; Zweckstetter M
Nat Commun; 2023 Sep; 14(1):5919. PubMed ID: 37739953
[TBL] [Abstract][Full Text] [Related]
2. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
3. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment
Shah SJA; Zhong H; Zhang Q; Liu H
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269542
[TBL] [Abstract][Full Text] [Related]
5. Charge neutralization of lysine via carbamylation reveals hidden aggregation hot-spots in tau protein flanking regions.
Gadhavi J; Shah S; Sinha T; Jain A; Gupta S
FEBS J; 2022 May; 289(9):2562-2577. PubMed ID: 34796642
[TBL] [Abstract][Full Text] [Related]
6. Disease-associated patterns of acetylation stabilize tau fibril formation.
Li L; Nguyen BA; Mullapudi V; Li Y; Saelices L; Joachimiak LA
Structure; 2023 Sep; 31(9):1025-1037.e4. PubMed ID: 37348495
[TBL] [Abstract][Full Text] [Related]
7. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
Dave N; Vural AS; Piras IS; Winslow W; Surendra L; Winstone JK; Beach TG; Huentelman MJ; Velazquez R
Acta Neuropathol; 2021 Aug; 142(2):279-294. PubMed ID: 33978814
[TBL] [Abstract][Full Text] [Related]
8. Tauopathy: A common mechanism for neurodegeneration and brain aging.
Saha P; Sen N
Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
[TBL] [Abstract][Full Text] [Related]
9. Cryo-EM structures of tau filaments.
Scheres SH; Zhang W; Falcon B; Goedert M
Curr Opin Struct Biol; 2020 Oct; 64():17-25. PubMed ID: 32603876
[TBL] [Abstract][Full Text] [Related]
10. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
[TBL] [Abstract][Full Text] [Related]
11. Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.
Kyalu Ngoie Zola N; Balty C; Pyr Dit Ruys S; Vanparys AAT; Huyghe NDG; Herinckx G; Johanns M; Boyer E; Kienlen-Campard P; Rider MH; Vertommen D; Hanseeuw BJ
Nat Commun; 2023 Jun; 14(1):3706. PubMed ID: 37349319
[TBL] [Abstract][Full Text] [Related]
12. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
13. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.
Grinberg LT; Wang X; Wang C; Sohn PD; Theofilas P; Sidhu M; Arevalo JB; Heinsen H; Huang EJ; Rosen H; Miller BL; Gan L; Seeley WW
Acta Neuropathol; 2013 Apr; 125(4):581-93. PubMed ID: 23371364
[TBL] [Abstract][Full Text] [Related]
14. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
15. The acetylation of tau inhibits its function and promotes pathological tau aggregation.
Cohen TJ; Guo JL; Hurtado DE; Kwong LK; Mills IP; Trojanowski JQ; Lee VM
Nat Commun; 2011; 2():252. PubMed ID: 21427723
[TBL] [Abstract][Full Text] [Related]
16. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation.
Cohen TJ; Constance BH; Hwang AW; James M; Yuan CX
PLoS One; 2016; 11(7):e0158470. PubMed ID: 27383765
[TBL] [Abstract][Full Text] [Related]
18. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies.
Ramachandran G; Udgaonkar JB
Biochemistry; 2013 Jun; 52(24):4107-26. PubMed ID: 23721410
[TBL] [Abstract][Full Text] [Related]
20. The Lys 280 → Gln mutation mimicking disease-linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties.
Kumar H; Udgaonkar JB
Protein Sci; 2021 Apr; 30(4):785-803. PubMed ID: 33496017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
